Griffin Asset Management’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $7.2M | Sell |
144,211
-83,074
| -37% | -$3.5M | 0.77% | 38 |
|
|
2026
Q2 | $6.3M | Buy |
227,285
+2,108
| +0.9% | +$49.7K | 0.66% | 48 |
|
|
2026
Q1 | $4.86M | Sell |
225,177
-1,135
| -0.5% | -$21K | 0.55% | 52 |
|
|
2025
Q4 | $3.11M | Sell |
226,312
-1,000
| -0.4% | -$15.6K | 0.34% | 76 |
|
|
2025
Q3 | $4.02M | Sell |
227,312
-2,347
| -1% | -$37.1K | 0.45% | 60 |
|
|
2025
Q2 | $3.47M | Sell |
229,659
-3,898
| -2% | -$64.7K | 0.41% | 70 |
|
|
2025
Q1 | $3.76M | Sell |
233,557
-3,990
| -2% | -$74.4K | 0.46% | 62 |
|
|
2024
Q4 | $4.14M | Sell |
237,547
-19,902
| -8% | -$351K | 0.49% | 56 |
|
|
2024
Q3 | $4.52M | Sell |
257,449
-230
| -0.1% | -$3.92K | 0.51% | 53 |
|
|
2024
Q2 | $2.88M | Sell |
257,679
-42,641
| -14% | -$402K | 0.33% | 71 |
|
|
2024
Q1 | $2.62M | Buy |
300,320
+40,700
| +16% | +$374K | 0.31% | 76 |
|
|
2023
Q4 | $3.18M | Sell |
259,620
-15,140
| -6% | -$105K | 0.4% | 67 |
|
|
2023
Q3 | $1.11M | Buy |
274,760
+80,410
| +41% | +$500K | 0.16% | 120 |
|
|
2023
Q2 | $1.4M | Buy |
194,350
+25,000
| +15% | +$160K | 0.19% | 111 |
|
|
2023
Q1 | $569K | Sell |
169,350
-6,543
| -4% | -$19.7K | 0.08% | 161 |
|
|
2022
Q4 | $487K | Buy |
175,893
+90,059
| +105% | +$202K | 0.07% | 160 |
|
|
2022
Q3 | $197K | Buy |
85,834
+17,383
| +25% | +$28.2K | 0.03% | 198 |
|
|
2022
Q2 | $105K | Sell |
68,451
-6,400
| -9% | -$16.1K | 0.02% | 207 |
|
|
2022
Q1 | $364K | Sell |
74,851
-1,108
| -1% | -$9.07K | 0.05% | 181 |
|
|
2021
Q4 | $1.12M | Buy |
75,959
+14,488
| +24% | +$289K | 0.14% | 134 |
|
|
2021
Q3 | $1.33M | Buy |
61,471
+3,000
| +5% | +$64.5K | 0.17% | 123 |
|
|
2021
Q2 | $959K | Hold |
58,471
| – | – | 0.12% | 146 |
|
|
2021
Q1 | $1.38M | Sell |
58,471
-28,308
| -33% | -$846K | 0.18% | 117 |
|
|
2020
Q4 | $2.07M | Buy |
86,779
+18,503
| +27% | +$294K | 0.27% | 81 |
|
|
2020
Q3 | $805K | Buy |
68,276
+26,452
| +63% | +$285K | 0.12% | 128 |
|
|
2020
Q2 | $437K | Sell |
41,824
-1,196
| -3% | -$10.8K | 0.07% | 156 |
|
|
2020
Q1 | $308K | Sell |
43,020
-6,765
| -14% | -$70.2K | 0.06% | 164 |
|
|
2019
Q4 | $668K | Buy |
49,785
+1,750
| +4% | +$24.9K | 0.09% | 143 |
|
|
2019
Q3 | $742K | Sell |
48,035
-9,280
| -16% | -$121K | 0.12% | 135 |
|
|
2019
Q2 | $757K | Buy |
57,315
+5,955
| +12% | +$81.2K | 0.1% | 162 |
|
|
2019
Q1 | $903K | Buy |
+51,360
| New | +$806K | 0.13% | 150 |
|
Other funds holding PLSE
Griffin Asset Management's PLSE Position: Q3 2026 in Review
Griffin Asset Management reduced its Pulse Biosciences (PLSE) stake by 37% in Q3 2026, selling an estimated $3.5M and leaving 144,211 shares worth $7.2M. The position accounts for 0.77% of the portfolio, ranked #38.
Griffin Asset Management first reported a position in PLSE in Q1 2019 and has held it in 31 quarters since. 59 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Griffin Asset Management held 144,211 shares of Pulse Biosciences worth $7.2M as of Q3 2026.
- Griffin Asset Management sold 83,074 Pulse Biosciences shares in Q3 2026, an estimated $3.5M.
- Pulse Biosciences made up 0.77% of Griffin Asset Management's portfolio in Q3 2026, its #38 holding.
- Griffin Asset Management first reported a position in Pulse Biosciences in Q1 2019 and has held it in 31 quarters since.
- 59 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Griffin Asset Management's 13F filing for Q3 2026, filed 22 Oct 2026.